Health Hour


The pharmaceutical exports of India have witnessed a remarkable growth of 103% in the last decade. India has made a global mark with manufacturing over 50% of the world’s vaccines and 20% of generic medicines. This phenomenal success can be attributed to world-class manufacturing, strong infrastructure, cost competitiveness, human capital, and innovation. Sudarshan Jain, the Secretary General of the Indian Pharmaceutical Alliance (a group of 24 leading research-based Indian pharmaceutical companies), aspires for the Indian pharma industry to be valued at $450 billion by 2047.

The COVID-19 pandemic brought to fore the dynamism of Indian pharma sector in the eyes of public. Companies like Aurobindo Pharma, led by Dr.M.Sivakumaran, Cipla, headed by Umang Vohra and Parmjit Arora’s Health Biotech were among some of the companies that ensured the successful delivery of vaccines. India supplied Vaccines to over 90+ countries during the pandemic and was lauded world over.

Parmjit Arora Health Biotech’s director believes in providing quality pharmaceuticals that can reach society far and wide, both in the Indian and international markets. “The endeavor is to be a focused and one of the largest finished pharmaceutical injectable tech and R&D based manufacturers in Asia”. Health Biotech provides world-class expertise in lyophilization product and process development. The company prides itself on consistently delivering parenteral products as economically and rapidly as possible. Health Biotech’s Remdesivir was a game changer for people impacted by the pandemic worldwide.

Union Minister for Health and Family Welfare, Dr. Mansukh Mandaviya, addressed the roundtable on ‘Opportunities in R&D and Innovation in Life Sciences’ at the World Economic Forum in Davos and remarked that “India is taking concerted and coordinated efforts on R&D and Innovation in the Pharma-MedTech Sector to develop cutting-edge products and technologies indigenously and promoting an enabling ecosystem for innovation to become a leader in drug discovery and innovative medical devices”.

Another segment that the government of India is actively investing in is the API (Active Pharmaceutical Ingredient). API contributes to around 35% of the market and India manufactures 500+ different APIs, making it a crucial component of the pharma industry. India is the 3rd largest producer accounting for an 8% share of the Global API Industry.  In 2020, the government approved 6,940 crore rupees for the PLI scheme for the promotion of domestic manufacturing of Key Starting Materials and APIs.

 With less than a week to go for the Budget, the pharma sector has high hopes with regards to the policy regime, simplified GST norms, and incentives to further push the output in R&D and innovation. In addition, the industry stands to benefit a lot from increased government schemes and initiatives for manufacturing and establishing a future oriented ‘value chain’ that supplies skilled professionals to the pharma sector in the coming years which would go a long way in giving the much-needed spurt to the pharma sector.

Over past years, the pharma industry has witnessed diverse collaborations and adopted innovative approaches to deliver the best quality medicines during various viral outbreaks world over and beyond. The sector has shown unwavering commitment to serve humanity, good results of which have enhanced the sector’s footprint across the globe. A bright future stands ahead for India’s pharmaceutical businesses in 2023.


Recent Posts

Will LGBTQIA+ ever be free? A big question mark on selective rights for LGBTQIA+

India is a democratic nation where no individual is deprived of their rights, but apparently,…

5 hours ago

Bheed: When Lockdown Became a Dark and Sad Reflection of Partition

Bheed, an upcoming drama movie by Anubhav Sinha, shot in black-and-white, depicts the country's gloomy…

7 days ago

India Makes History: Naatu Naatu bags Oscar for Best Original Song

Billions of Indians rejoiced when the energetic dance track-Naatu Naatu from the movie RRR received…

1 week ago

India and US Strengthen Technology Partnership: Boosting Investment, Innovation, and Growth

“America sees India as a trusted technology partner, and it wants to deepen this technological…

1 week ago

A robotic arm that can 3D bioprint inside the human body

The future of medical technology has landed, and it's nothing short of revolutionary. Imagine a…

1 week ago

India-Pakistan Relations: Tensions, Multilateral Engagements, and the Role of the United States in Facilitating Constructive Dialogue

The United States has reiterated its support for constructive dialogue between India and Pakistan to…

1 week ago